Moody Aldrich Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-224,831
| Closed | -$3.33M | – | 215 |
|
|
2024
Q1 | $3.33M | Buy |
+224,831
| New | +$3.33M | 0.57% | 77 |
|
|
2021
Q1 | – | Sell |
-101,161
| Closed | -$4.69M | – | 192 |
|
|
2020
Q4 | $4.69M | Buy |
101,161
+35,454
| +54% | +$1.65M | 0.76% | 65 |
|
|
2020
Q3 | $2.16M | Buy |
65,707
+952
| +1% | +$31.3K | 0.45% | 87 |
|
|
2020
Q2 | $1.78M | Sell |
64,755
-20,030
| -24% | -$550K | 0.38% | 87 |
|
|
2020
Q1 | $2.54M | Sell |
84,785
-89
| -0.1% | -$2.66K | 0.77% | 57 |
|
|
2019
Q4 | $2.35M | Buy |
84,874
+1,311
| +2% | +$36.3K | 0.48% | 82 |
|
|
2019
Q3 | $1.52M | Sell |
83,563
-842
| -1% | -$15.3K | 0.4% | 83 |
|
|
2019
Q2 | $2.07M | Buy |
+84,405
| New | +$2.07M | 0.53% | 71 |
|